Remdesivir

General

Type : Pro-Drug || Drug || Not A\/B H target || Propionate || Triazine

Chemical_Nomenclature : 2-ethylbutyl (2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate

Canonical SMILES : CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4

InChI : InChI=1S\/C27H35N6O8P\/c1-4-18(5-2)13-38-26(36)17(3)32-42(37,41-19-9-7-6-8-10-19)39-14-21-23(34)24(35)27(15-28,40-21)22-12-11-20-25(29)30-16-31-33(20)22\/h6-12,16-18,21,23-24,34-35H,4-5,13-14H2,1-3H3,(H,32,37)(H2,29,30,31)\/t17-,21+,23+,24+,27-,42-\/m0\/s1

InChIKey : RWWYLEGWBNMMLJ-YSOARWBDSA-N

Other name(s) : 3QKI37EEHE,     GS 5734,     GS-5734,     CHEMBL4065616,     SCHEMBL17712225,     CHEBI:145994


MW : 602.6

Formula : C27H35N6O8P

CAS_number : 1809249-37-3

PubChem :

UniChem :

Iuphar :

References (8)

Title : Assessing in vitro stability of remdesivir (GS-5734) and conversion to GS-441524 in feline plasma and whole blood - Coggins_2024_Vet.Q_44_1
Author(s) : Coggins SJ , Kimble B , Malik R , Thompson MF , Norris JM , Govendir M
Ref : Vet Q , 44 :1 , 2024
Abstract : Coggins_2024_Vet.Q_44_1
ESTHER : Coggins_2024_Vet.Q_44_1
PubMedSearch : Coggins_2024_Vet.Q_44_1
PubMedID: 38288972

Title : Remdesivir potently inhibits carboxylesterase-2 through covalent modifications: signifying strong drug-drug interactions - Shen_2021_Fundam.Clin.Pharmacol_35_432
Author(s) : Shen Y , Eades W , Yan B
Ref : Fundamental & Clinical Toxicology , 35 :432 , 2021
Abstract : Shen_2021_Fundam.Clin.Pharmacol_35_432
ESTHER : Shen_2021_Fundam.Clin.Pharmacol_35_432
PubMedSearch : Shen_2021_Fundam.Clin.Pharmacol_35_432
PubMedID: 33369768
Gene_locus related to this paper: human-CES2

Title : Key Metabolic Enzymes Involved in Remdesivir Activation in Human Lung Cells - Li_2021_Antimicrob.Agents.Chemother__AAC0060221
Author(s) : Li R , Liclican A , Xu Y , Pitts J , Niu C , Zhang J , Kim C , Zhao X , Soohoo D , Babusis D , Yue Q , Ma B , Murray BP , Subramanian R , Xie X , Zou J , Bilello JP , Li L , Schultz BE , Sakowicz R , Smith BJ , Shi PY , Murakami E , Feng JY
Ref : Antimicrobial Agents & Chemotherapy , :AAC0060221 , 2021
Abstract : Li_2021_Antimicrob.Agents.Chemother__AAC0060221
ESTHER : Li_2021_Antimicrob.Agents.Chemother__AAC0060221
PubMedSearch : Li_2021_Antimicrob.Agents.Chemother__AAC0060221
PubMedID: 34125594

Title : Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside - Tao_2021_Curr.Res.Pharmacol.Drug.Discov_2_100045
Author(s) : Tao S , Zandi K , Bassit L , Ong YT , Verma K , Liu P , Downs-Bowen JA , McBrayer T , LeCher JC , Kohler JJ , Tedbury PR , Kim B , Amblard F , Sarafianos SG , Schinazi RF
Ref : Curr Res Pharmacol Drug Discov , 2 :100045 , 2021
Abstract : Tao_2021_Curr.Res.Pharmacol.Drug.Discov_2_100045
ESTHER : Tao_2021_Curr.Res.Pharmacol.Drug.Discov_2_100045
PubMedSearch : Tao_2021_Curr.Res.Pharmacol.Drug.Discov_2_100045
PubMedID: 34870151

Title : Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV - Sheahan_2020_Nat.Commun_11_222
Author(s) : Sheahan TP , Sims AC , Leist SR , Schafer A , Won J , Brown AJ , Montgomery SA , Hogg A , Babusis D , Clarke MO , Spahn JE , Bauer L , Sellers S , Porter D , Feng JY , Cihlar T , Jordan R , Denison MR , Baric RS
Ref : Nat Commun , 11 :222 , 2020
Abstract : Sheahan_2020_Nat.Commun_11_222
ESTHER : Sheahan_2020_Nat.Commun_11_222
PubMedSearch : Sheahan_2020_Nat.Commun_11_222
PubMedID: 31924756

Title : Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19 - Eastman_2020_ACS.Cent.Sci_6_672
Author(s) : Eastman RT , Roth JS , Brimacombe KR , Simeonov A , Shen M , Patnaik S , Hall MD
Ref : ACS Cent Sci , 6 :672 , 2020
Abstract : Eastman_2020_ACS.Cent.Sci_6_672
ESTHER : Eastman_2020_ACS.Cent.Sci_6_672
PubMedSearch : Eastman_2020_ACS.Cent.Sci_6_672
PubMedID: 32483554

Title : Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease - Agostini_2018_mBio_9_
Author(s) : Agostini ML , Andres EL , Sims AC , Graham RL , Sheahan TP , Lu X , Smith EC , Case JB , Feng JY , Jordan R , Ray AS , Cihlar T , Siegel D , Mackman RL , Clarke MO , Baric RS , Denison MR
Ref : MBio , 9 : , 2018
Abstract : Agostini_2018_mBio_9_
ESTHER : Agostini_2018_mBio_9_
PubMedSearch : Agostini_2018_mBio_9_
PubMedID: 29511076